Sterling Capital Management’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.68K	Buy	697 +271	+64%	+$1.82K	﹤0.01%	2546
2025 Q1	$3.85K	Sell	426 -366	-46%	-$3.31K	﹤0.01%	2289
2024 Q4	$13.7K	Buy	792 +702	+780%	+$12.1K	﹤0.01%	2012
2024 Q3	$1.44K	Buy	+90	New	+$1.44K	﹤0.01%	2356